Comparing immunotherapies to other frequently used treatments of gastric cancer-Reference-Cited by-同舟云学术

Comparing immunotherapies to other frequently used treatments of gastric cancer

Published:2021-07-27 Issue:10 Volume:14 Page:1221-1232
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Basile Debora¹,Simionato Francesca¹,Calvetti Lorenzo¹,Cappetta Alessandro¹,Pesavento Annalisa¹²,Mongillo Marta¹²,Roviello Giandomenico³,Rosati Gerardo⁴^ORCID,Rossi Gemma⁴,Aprile Giuseppe¹

Affiliation:

1. Department of Oncology, San Bortolo General Hospital, Vicenza, Italy

2. Oncology Unit, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy

3. Department of Health Sciences, University of Florence, Florence, Italy

4. Medical Oncology, San Carlo General Hospital, Potenza, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2021.1938546

Reference124 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. Surgical management of advanced gastric cancer: An evolving issue

3. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

4. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

5. Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification and characterization of ferroptosis-related genes in therapy-resistant gastric cancer;Medicine;2024-05-17

2. The ZuoJinWan formula inhibits glycolysis of cisplatin resistant gastric cancer cells via p53 acetylation;Pharmacological Research - Modern Chinese Medicine;2024-03

3. Polyphyllin I suppresses the gastric cancer growth by promoting cancer cell ferroptosis;Frontiers in Pharmacology;2023-04-04

4. Construction of a Prognostic Predicting Model for Advanced Gastric Cancer Patients Treated with PD-1 Inhibitors in Combination with Taxane-Based Chemotherapy;J BIOL REG HOMEOS AG;2022